Acylated and alkylated histamine derivatives as new histamine H3-receptor antagonists
- 31 December 1994
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 29 (9) , 695-700
- https://doi.org/10.1016/0223-5234(94)90031-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Histamine H3 receptors modulate the release of [3H]‐acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypesBritish Journal of Pharmacology, 1992
- Synthesis, absolute configuration, stereoselectivity, and receptor selectivity of (.alpha.R,.beta.S)-.alpha.,.beta.-dimethylhistamine. A novel highly potent histamine H3 receptor agonistJournal of Medicinal Chemistry, 1992
- Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein by presynaptic histamine H3 receptorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1992
- Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the catBrain Research, 1990
- Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortexNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- Highly potent and selective ligands for histamine H3-receptorsNature, 1987
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983
- Potential histamine H2-receptor antagonists. 3. MethylhistaminesJournal of Medicinal Chemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973